Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Noninterventional, Multicentre Trial of Rituximab in Combination With Chemotherapy (CVP, CHOP or FCM) Chemotherapy in Patients With Follicular Lymphoma

NCT02461290 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02461290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02461290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Noninterventional, Multicentre Trial of Rituximab in Combination With Chemotherapy (CVP, CHOP or FCM) Chemotherapy in Patients With Follicular Lymphoma
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
November 30, 2013
Enrollment
99 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma